secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lumexa Imaging Holdings, Inc. (LMRI)
CIK:        0002071288
Form:       8-K
Filed at:   2026-08-12T20:05:10+00:00
Accession:  0001193125-26-346813
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lumexa Imaging Q2 revenue up 5.1% to $264.2M; turns to net income of $2.7M
--------------------------------------------------------------------------

- Q2 revenue $264.2M, up 5.1% YoY from $251.4M; system-wide growth 6.0%.
- Net income $2.7M vs net loss $7.2M; GAAP EPS $0.03, adjusted EPS $0.20.
- Adjusted EBITDA $56.4M vs $56.3M; margin 21.4% vs 22.4%.
- FY2026 guidance: revenue reaffirmed $1.045-1.097B; Adj EBITDA narrowed to $235-241M; Adj EPS $0.71-0.77.
- Announced four new imaging centers YTD and JV with Hospital for Special Surgery (HSS).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2071288/000119312526346813/0001193125-26-346813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2071288/000119312526346813/d113773d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-346813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer